Technology-assisted rehabilitation interventions following pediatric brain injury.
Journal of Neurosurgical Sciences
Edizioni Minerva Medica
© 2017 Edizioni Minerva Medica
Reason for embargo
Under embargo until 20 November 2018 in compliance with publisher policy.
INTRODUCTION: Following traumatic brain injury (TBI), children experience a variety of physical, motor, speech, and cognitive deficits that can have a long-term detrimental impact. The emergence and popularity of new technologies has led to research into the development of various apps, gaming systems, websites, and robotics that might be applied to rehabilitation. The objective of this narrative review was to describe the current literature technologically-assisted interventions for the rehabilitation of motor, neurocognitive, behavioral, and family impairments following pediatric TBI. EVIDENCE ACQUISITION: We conducted a series of searches for peer-reviewed manuscripts published between 2000 and 2017 that included a technology-assisted component in the domains of motor, language/communication, cognition, behavior, social competence/functioning, family, and academic/school-based functioning. EVIDENCE SYNTHESIS: Findings suggested several benefits of utilizing technology in TBI rehabilitation including facilitating engagement/adherence, increasing access to therapies, and improving generalizability across settings. There is fairly robust evidence regarding the efficacy of online family problem-solving therapy in improving behavior problems, executive functioning, and family functioning. There was less compelling, but still promising, evidence regarding the efficacy other technology for motor deficits, apps for social skills, and computerized programs for cognitive skills. Overall, many studies were limited in the rigor of their methodology due to small heterogeneous samples and lack of control groups. CONCLUSIONS: Technology-assisted interventions have the potential to enhance pediatric rehabilitation after TBI. Future research is needed to further support their efficacy with larger controlled trials and to identify characteristics of children who are most likely to benefit.
The development of this manuscript was supported by funding from the Patient Centered Outcomes Research Institute (PCORI-CER-1306-02435) and National Institute of Child Health and Human Development (R21 Grant info). Dr. Megan Narad was also supported by funds from NICHD 1F32HD088011-01. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH or PCORI.
This is the author accepted manuscript. The final version is available from Edizioni Minerva Medica via the DOI in this record.
Place of publication